Astrocytoma of brain
Information
- Disease name
- Astrocytoma of brain
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03020602 | Completed | Phase 1 | BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab | January 4, 2017 | June 26, 2021 |
| NCT04091503 | Completed | Phase 1 | Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma | December 20, 2019 | October 28, 2022 |
| NCT05518994 | Not yet recruiting | Phase 2 | Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Astrocytoma | December 1, 2022 | December 2027 |
| NCT06283927 | Recruiting | The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) | January 1, 2023 | January 1, 2028 |